TickerFactsScreenerDevelopers

Quince Therapeutics, Inc. (QNCX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$20.28M2018: -$32.63M2019: $115.48M2020: $172.26M2021: $118.59M2022: $100.59M2023: $85.08M2024: $30.15M2025: -$35.71M-$35.71M
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$35.71M-218.5%
2024$30.15M-64.6%
2023$85.08M-15.4%
2022$100.59M-15.2%
2021$118.59M-31.2%
2020$172.26M+49.2%
2019$115.48M+453.9%
2018-$32.63M-60.9%
2017-$20.28M—